Skip to main content

iBio, Inc.

IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001420720

No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in iBio, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
83
−6 vs. Q3 2021
Shares held
45.4M
+740.9K (+1.7%) vs. Q3 2021
Total value
$25.0M
−$22.5M (−47.4%) vs. Q3 2021
New holders
11
26 more added
Sold out
17
22 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 83 institutions
Q1 2021: 94 institutionsQ2 2021: 87 institutionsQ3 2021: 90 institutionsQ4 2021: 83 institutionsQ1 2022: 77 institutionsQ2 2022: 57 institutionsQ3 2022: 46 institutionsQ4 2022: 38 institutionsQ1 2023: 30 institutionsQ2 2023: 29 institutionsQ3 2023: 29 institutionsQ4 2023: 21 institutionsQ1 2024: 28 institutionsQ2 2024: 28 institutionsQ3 2024: 32 institutionsQ4 2024: 30 institutionsQ1 2025: 34 institutionsQ2 2025: 30 institutionsQ3 2025: 32 institutionsQ4 2025: 50 institutionsQ1 2026: 52 institutionsQ2 2026: 55 institutions
Value heldQ4 2021: $25.0M
Q1 2021: $68.5MQ2 2021: $65.5MQ3 2021: $47.6MQ4 2021: $25.0MQ1 2022: $17.5MQ2 2022: $7.63MQ3 2022: $4.97MQ4 2022: $1.02MQ1 2023: $3.45MQ2 2023: $695.7KQ3 2023: $269.9KQ4 2023: $344.6KQ1 2024: $11.5MQ2 2024: $5.68MQ3 2024: $5.79MQ4 2024: $6.40MQ1 2025: $10.4MQ2 2025: $2.44MQ3 2025: $2.96MQ4 2025: $31.6MQ1 2026: $36.9MQ2 2026: $60.8M
Institutions holding IBIO and their total value by quarter
QuarterHoldersValue
Q2 202655$60.8M
Q1 202652$36.9M
Q4 202550$31.6M
Q3 202532$2.96M
Q2 202530$2.44M
Q1 202534$10.4M
Q4 202430$6.40M
Q3 202432$5.79M
Q2 202428$5.68M
Q1 202428$11.5M
Q4 202321$344.6K
Q3 202329$269.9K
Q2 202329$695.7K
Q1 202330$3.45M
Q4 202238$1.02M
Q3 202246$4.97M
Q2 202257$7.63M
Q1 202277$17.5M
Q4 202183$25.0M
Q3 202190$47.6M
Q2 202187$65.5M
Q1 202194$68.5M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding iBio, Inc.; share changes are against Q3 2021.

Institutions holding IBIO in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
HighPoint Advisor Group LLC––––Not filed